Pictet Asset Management (Switzerland)’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-121,394
Closed -$597K – 2046
2022
Q4
$597K Sell
121,394
-72,151
-37% -$597K ﹤0.01% 1174
2022
Q3
$2.18M Hold
193,545
– – ﹤0.01% 912
2022
Q2
$2.65M Sell
193,545
-20,342
-10% -$476K ﹤0.01% 892
2022
Q1
$11.1M Sell
213,887
-6,181
-3% -$273K 0.01% 624
2021
Q4
$12.9M Sell
220,068
-5,730
-3% -$429K 0.01% 607
2021
Q3
$22.7M Buy
+225,798
New +$23.3M 0.03% 486

Other funds holding MTEM

Pictet Asset Management (Switzerland)'s MTEM Position: Q1 2023 in Review

Pictet Asset Management (Switzerland) sold out of Molecular Templates, Inc. (MTEM) in Q1 2023, closing a stake of 121,394 shares — an estimated $597K sold.

Pictet Asset Management (Switzerland) first reported a position in MTEM in Q3 2021 and held it in 6 quarters. The position peaked at $22.7M in Q3 2021. 41 funds tracked by Wall St. Rank hold MTEM as of Q1 2023.

  • Pictet Asset Management (Switzerland) reported no remaining Molecular Templates, Inc. position as of Q1 2023 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 121,394 Molecular Templates, Inc. shares in Q1 2023, an estimated $597K.
  • Pictet Asset Management (Switzerland) first reported a position in Molecular Templates, Inc. in Q3 2021 and held it in 6 quarters.
  • Pictet Asset Management (Switzerland)'s Molecular Templates, Inc. position peaked at $22.7M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 10 May 2023.